MedPath

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

Phase 3
Terminated
Conditions
Primary Insomnia
Registration Number
NCT00094666
Lead Sponsor
H. Lundbeck A/S
Brief Summary

The purpose of the study is to test the safety and effectiveness of an Investigational Drug on insomnia in the elderly.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
465
Inclusion Criteria
  • Elderly patients with a diagnosis of primary insomnia and in good physical and mental health
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Amount of time spent awake and time to fall asleep at night after two days
Secondary Outcome Measures
NameTimeMethod
Amount of deep sleep after two days
Amount of time spent awake and time to fall asleep at night after 30 days
© Copyright 2025. All Rights Reserved by MedPath